drugset / Trial / NCT03158480

Safety and Efficacy of Immune Therapy for Condyloma

NCT03158480

Unknown 80 enrolled Shenzhen Second People's Hospital
RandomizedParallel-groupTriple-blindTreatment

Summary

Cytokine-induced killer (CIK) cells will be co-cultured with HPV induced dendritic cells (DCs); HPV specific DC-CIK will be induced to Condylomata Acuminata patients using interferon, whose recurrence rate and total cost will be compared to Condylomata Acuminata patients only use interferon.

Timeline

Start
2017-06-25
Primary completion
2018-12-31
Completion
2019-06-30

Drugs

EvaluationDrugModalityDoseRoute
Subject DC-CIK Cell therapy